The results of the present examples show that anti-EGF antibody levels are significantly lower in patients with ovarian cancer compared to healthy controls. In addition, levels are significantly higher in patients who do not relapse after treatment with panitumumab or chemotherapeutic agents. Levels of anti-EGF antibodies in samples are a well-suited predictor of response to…
The 2nd Symposium on Regulatory Autoantibodies Targeting G-Protein-Coupled Receptors takes place from 28th to 30th September 2018 in Lübeck. Internationally renowned scientists give news about GPCRs. We look forward to seeing you there! link to the symposium website
The US National Institute of Neurological Disorders and Stroke (NINDS), one of the most renowned neuroscience research institutes, has included our antibody determinations in its recommendations for the diagnosis of CFS / ME. F2765_Laboratory_Tests_Immune_Module.pdf (291,0 KiB)
Dr. Lasse Giil et al., Haraldsplass Hospital Bergen, describes the association between multiple antibodies an neuropsychiatric symptoms and Mortality in Alzheimer’s patients. https://www.ncbi.nlm.nih.gov/pubmed/29914018
